VG901
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for VG901, covering 2025-03-28 to 2025-03-28. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Tolerability of Intravitreal Administration of VG901 in Patients With Retinitis Pigmentosa Due to Mutations in the CNGA1 Gene [Phase 1]